Lara Aprile

Residual Peripheral Blood CD26+ Leukemic Stem Cells in Chronic Myeloid Leukemia Patients During TKI Therapy and During Treatment-Free Remission

Monica Bocchia, Anna Sicuranza, Elisabetta Abruzzese et al. · Frontiers in Oncology · 2018 · 105 citations · Full text

Medicine, Hematology, Oncology +17

Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T‐cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study

Anna Candoni, Davide Lazzarotto, Felicetto Ferrara et al. · American Journal of Hematology · 2020 · 70 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients

Monica Bocchia, Sara Galimberti, Lara Aprile et al. · Oncotarget · 2016 · 29 citations · Full text

Medicine, Hematology, Pharmacology +13

Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study

Michele Malagola, Alessandra Iurlo, Elisabetta Abruzzese et al. · Cancer Medicine · 2021 · 17 citations · Full text

Medicine, Hematology, Pharmacotherapy +13

Evaluation of residual CD34⁺Ph⁺ progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first‐line nilotinib therapy

Marzia Defina, Micaela Ippoliti, Alessandro Gozzetti et al. · Cancer · 2012 · 14 citations

Life Sciences, Molecular Biology, Oncology +15